Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
606
-
Total 13F shares, excl. options
-
49.4M
-
Shares change
-
-708K
-
Total reported value, excl. options
-
$10.8B
-
Value change
-
-$104M
-
Put/Call ratio
-
1.51
-
Number of buys
-
300
-
Number of sells
-
-256
-
Price
-
$217.90
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2022
683 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q4 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 606 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.4M shares
of 49.7M outstanding shares and own 99.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.96M shares), BlackRock Inc. (4.96M shares), STATE STREET CORP (2.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.85M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.62M shares), Clearbridge Investments, LLC (1.37M shares), Allspring Global Investments Holdings, LLC (1.15M shares), GEODE CAPITAL MANAGEMENT, LLC (1.04M shares), Invesco Ltd. (899K shares), and MARSHALL WACE, LLP (875K shares).
This table shows the top 606 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.